Literature DB >> 12433667

Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying.

Sara Calatayud1, Eugenia García-Zaragozá, Carlos Hernández, Elsa Quintana, Vicente Felipo, Juan Vicente Esplugues, María Dolores Barrachina.   

Abstract

A single intraperitoneal injection of endotoxin (40 microg/kg) significantly delayed gastric emptying of a solid nutrient meal. Blockade of nitric oxide synthase (NOS) with 30 mg/kg ip N(G)-nitro-L-arginine methyl ester or 20 mg/kg ip 7-nitroindazole [neuronal NOS (nNOS) inhibitor] significantly delayed gastric emptying in control animals but failed to modify gastric emptying in endotoxin-treated rats. Administration of 2.5, 5, and 10 mg/kg ip N(6)-iminoethyl-L-lysine [inducible NOS (iNOS) inhibitor] had no effect in either experimental group. Indomethacin (5 mg/kg sc), NS-398 (cyclooxygenase-2 inhibitor; 10 mg/kg ip), and dexamethasone (10 mg/kg sc) but not quinacrine (20 mg/kg ip) significantly prevented delay in gastric emptying induced by endotoxin but failed to modify gastric emptying in vehicle-treated animals. Ca(2+)-dependent NOS activity in the antrum pylorus of the stomach was diminished by endotoxin, whereas Ca(2+)-independent NOS activity was not changed. In addition, decreased nNOS mRNA and protein were observed in the antrum pylorus of endotoxin-treated rats. Our results suggest that downregulation of nNOS in the antrum pylorus of the stomach and synthesis of prostaglandins mediate the delay in gastric emptying of a solid nutrient meal induced by endotoxin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433667     DOI: 10.1152/ajpgi.00168.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  14 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Novel mechanism for impaired nitrergic relaxation in achalasia.

Authors:  G E Boeckxstaens
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 3.  Gastrointestinal malignancy and the microbiome.

Authors:  Maria T Abreu; Richard M Peek
Journal:  Gastroenterology       Date:  2014-01-07       Impact factor: 22.682

Review 4.  The impact of proton pump inhibitors on the human gastrointestinal microbiome.

Authors:  Daniel E Freedberg; Benjamin Lebwohl; Julian A Abrams
Journal:  Clin Lab Med       Date:  2014-09-24       Impact factor: 1.935

Review 5.  Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis.

Authors:  Gen Kusaka; Kaname Uno; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

6.  Interstitial cells of Cajal are involved in the afferent limb of the rectoanal inhibitory reflex.

Authors:  F de Lorijn; W J de Jonge; T Wedel; J M Vanderwinden; M A Benninga; G E Boeckxstaens
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 7.  Microbiome of the Aerodigestive Tract in Health and Esophageal Disease.

Authors:  Aws Hasan; Laith K Hasan; Bernd Schnabl; Madeline Greytak; Rena Yadlapati
Journal:  Dig Dis Sci       Date:  2020-11-24       Impact factor: 3.199

Review 8.  Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.

Authors:  Liying Yang; Fritz Francois; Zhiheng Pei
Journal:  Clin Cancer Res       Date:  2012-02-16       Impact factor: 12.531

9.  Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus.

Authors:  S Bruley des Varannes; J Chevalier; S Pimont; J-C Le Neel; M Klotz; K-H Schafer; J-P Galmiche; M Neunlist
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

Review 10.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.